Job title:
PhD Research Opportunity:The Value of Pharmacogenomic testing in primary care for the prevention on inappropriate prescribing in polypharmacy populations and the wider societal and economic impacts (THRIVE 12)
Company
Job description
Offer DescriptionThe Higher Education Authority (HEA) Technological University Research and Innovation Supporting Enterprise, Scheme (TU RISE) is co-financed by the Government of Ireland and the European Union through the European Regional Development Fund (ERDF) via the Southern, Eastern & Midland Regional Programme 2021- 27 and the Northern & Western Regional Programme 2021-27The Postgraduate Research Programme Translational Health Research Innovation preVention & Equity (THRIVE) offers 12 PhD research scholarships to commence in 2024. Each project will include an enterprise placement of minimum 12 weeks duration.PhD Project Title: (THRIVE 12)The Value of Pharmacogenomic testing in primary care for the prevention on inappropriate prescribing in polypharmacy populations and the wider societal and economic impactsIn the Republic of Ireland (RoI) the budget allocated for health has increased by 80% over the last decade. This is due to increasing demands on healthcare as the population is living longer and innovation in pharmacologic therapies and medical devices have resulted in higher costs of care. Polypharmacy occurs when an individual is on more than five prescribed medications for different indications coinciding with potentially inappropriate prescribing (PIP), thus, areas where innovative practices may improve prescribing, reduce waste, reduce spending and ultimately enhances health related quality of life (HRQoL). Pharmacogenomics-informed prescribing has been evidenced to potentially improve efficacy and reduce adverse drug reactions, a leading cause of global mortality. For example, an estimated 42% of codeine prescriptions require adjustment based on pharmacogenomic data with approximately 2% of the population are at significant risk of codeine overdose because of a pharmacogenomic variant. Clinical guidelines on dose adjustments/alternative therapies are established based on pharmacogenomic metabolising status. The STOPP criteria is a useful screening tool for older persons prescribing but are best used in conjunction with clinical assessment and discretion, such adoption is varied across the RoI. This project aims to examine the value of pharmacogenomic testing in primary care for the prevention of PIP.Key Terms / areas: health informatics, health policy and health economicsProject Objectives:1. Investigate practices on polypharmacy management and PIP review across the RoI and internationally adopting a mixed-methods approach.2. Determine drivers of variation across nationally and internationally.3. Examine the international evidence on value propositions developed to support models of care involving polypharmacy management and pharmacogenomic testing.4. Develop an economic predictive model to ascertain short/ long terms benefits and cost-effectiveness of various intervention modalities adopting pharmacogenomic testing in primary care.5. Develop a value proposition for the introduction of pharmacogenomic testing for the prevention of PIPRequirements/QualificationsA minimum of 2.1 honours degree (Level 8) in a relevant discipline.Project Duration:48 months (PhD)Preferred Location:ATU Sligo CampusApplications:Application Form / Terms and Conditions can be obtained on the website:The closing date for receipt of applications is 5pm, (GMT) Monday 29th April, 2024.Only selected applicants will be called for an online interview (shortlisting may apply).RequirementsResearch Field Other Education Level Bachelor Degree or equivalentLanguages ENGLISH Level GoodAdditional InformationWork Location(s)Number of offers available 1 Company/Institute Atlantic Technological University Country Ireland GeofieldWhere to apply WebsiteContact WebsiteE-Mail[email protected]STATUS: EXPIRED
Expected salary
Location
Ireland
Job date
Wed, 17 Apr 2024 03:19:52 GMT
To help us track our recruitment effort, please indicate in your email/cover letter where (jobsnear.org) you saw this job posting.
